Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FZC57
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,311
Award facts
- Contract value 100% obligated
- $4,311.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On August 13, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, contract number 4569076114, calls for the supply of Xtandi 40 mg capsules in quantities of 120 units. This firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance taking place at the contractor's Park Ridge, Illinois facility. No set-aside designation was utilized for this award.
This delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. As a key supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group routinely fulfills delivery orders for branded and generic prescription drugs, biologics, and medical consumables serving military health facilities. The award of this Xtandi delivery order reflects the contractor's continued role in providing critical pharmaceutical products to DoD healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FZC57?
SPE2DB25FZC57 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FZC57 worth?
The government has obligated $4,311 on SPE2DB25FZC57.
Is contract SPE2DB25FZC57 an order under another contract?
Yes. SPE2DB25FZC57 is a delivery order under SPE2DB22D9143, an indefinite delivery contract.
Was contract SPE2DB25FZC57 competed?
The extent of competition for SPE2DB25FZC57 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award